Livivos

09/26/2025

𝗚𝗿𝗲𝗮𝘁 𝗡𝗲𝘄𝘀!
𝗟𝗶𝘃𝗶𝘃𝗼𝘀, 𝗜𝗻𝗰. 𝗔𝘄𝗮𝗿𝗱𝗲𝗱 𝗣𝗵𝗮𝘀𝗲 𝗜𝗜 𝗡𝗜𝗛 𝗚𝗿𝗮𝗻𝘁 𝘁𝗼 𝗔𝗱𝘃𝗮𝗻𝗰𝗲 𝗟𝗶𝘃𝗲𝗿𝗦𝗰𝗼𝗽𝗲® 𝗗𝗲𝘃𝗶𝗰𝗲
https://www.einpresswire.com/article/852239405/livivos-inc-awarded-phase-ii-nih-grant-to-advance-liverscope-device
Livivos has been awarded a $1.7M Phase II Small Business Innovation Research (SBIR) grant.
This NIH funding supports regulatory clearance and commercialization of the LiverScope®, Livivos’s point-of-care diagnostic device designed to expand access to quantitative liver disease testing and treatment monitoring. The grant also strengthens our collaboration with Dr. Claude Sirlin's Liver Imaging Group at the University of California San Diego.
We are grateful for this support as we continue advancing an innovative solution for patients, clinicians, and healthcare systems.

Learn more about our journey: www.livivos.com

CAUTION - Investigational device. Limited by Federal (or United States) law to investigational use.

04/09/2024

Livivos, Inc. announces appointment of Mr. Jerry Mabary as Director of Commercialization.
We are thrilled to announce the appointment of Mr. Jerry Mabary as Livivos's Director of Commercialization! Mr. Mabary brings a wealth of expertise to support the introduction of the LiverScope, Livivos's transformative point of care liver disease diagnostic device.

https://www.einnews.com/pr_news/701931020/livivos-inc-announces-appointment-of-mr-jerry-mabary-as-director-of-commercialization

www.livivos.com

11/08/2023

Livivos, Inc. announces appointment of Dr. Julio Gutierrez as Director of Clinical Development. https://world.einnews.com/pr_news/667045560/livivos-inc-announces-appointment-of-dr-julio-gutierrez-as-director-of-clinical-development

We are thrilled to announce the appointment of Dr. Julio Gutierrez as Livivos's Director of Clinical Development. Dr. Gutierrez brings a wealth of expertise to support our innovative diagnostic initiatives.

www.livivos.com Julio Gutierrez MD.

10/03/2023

Meet with us at the Medtech Conference in Anaheim, California! October 9-11. We love sharing the progress with the LiverScope®, our market-disruptive accurate liver disease diagnostic device.
Book your meeting with the Medtech Conference app.


www.livivos.com

LiverScope® is an investigational device. Limited by Federal law to investigational use.

09/13/2023

https://www.globenewswire.com/news-release/2023/09/13/2742550/0/en/Madrigal-Pharmaceuticals-Announces-NDA-Acceptance-and-Priority-Review-of-the-New-Drug-Application-for-Resmetirom-for-the-Treatment-of-NASH-with-Liver-Fibrosis.html

CONSHOHOCKEN, Pa., Sept. 13, 2023 (GLOBE NEWSWIRE) -- Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL), a clinical-stage biopharmaceutical company pursuing...

08/22/2023

Coming up next week! The Magnetic Resonance methodologies introduced with the LiverScope® will be showcased at the International Conference on Magnetic Resonance Microscopy (ICMRM) in Singapore (August 27-31, 2023). https://icmrm2023.sciencesconf.org/
Stay updated at www.livivos.com for more about the LiverScope®'s journey.

Livivos, Inc

07/19/2023

Exciting news! The Magnetic Resonance methodologies introduced with the ® will be showcased at the International Conference on Magnetic Resonance Microscopy (ICMRM) in Singapore (August 27-31, 2023). This conference aims to promote recent advancements in high-resolution, spatially resolved Magnetic Resonance methods and applications. https://lnkd.in/gMRD8HQ2
Livivos's CEO, Pablo Prado, Ph.D., will present the innovative point-of-care modalities entering clinical diagnostics, focusing on pioneering MR technologies to measure indicators of liver disease - current and upcoming biomarkers. Stay updated at www.livivos.com for more about the LiverScope®'s journey.

Livivos, Inc

07/13/2023

Introducing , transformative liver disease diagnostics

05/04/2023

Livivos is excited to announce the kickoff of a clinical study of our LiverScope® device. Read about it here https://tinyurl.com/2p9erh5e, and and give us a like while you're visiting!

04/23/2023

Livivos CEO Dr. Pablo Prado offers a detailed update on Livivos's progress.

Livivos is embarking on an exciting journey!... fueled by a strong belief that accurate and broadly-accessible liver disease diagnosis has the potential to be…

03/20/2023

See you in Dana Point! Livivos is attending.
If you are attending this week's Life Science Intelligence (LSI) summit, let's meet to discuss Livivos's business progress and the introduction of our transformative point of care liver disease diagnostic device. http://livivos.com/

LSI USA 2023 is bringing together leading innovators and active investors. https://www.lifesciencemarketresearch.com/medtech-summit-2023

02/26/2023

Great news! Livivos has been selected to pitch at the upcoming MedTech Innovator meeting in Los Angeles. The aims to "improve the lives of patients by accelerating the growth of companies that are transforming the healthcare system".
Out of over 1,000 companies that applied, Livivos was chosen as one of the 200 to present. We are thrilled to have the opportunity to showcase our game-changing approach to improving healthcare delivery.
https://medtechinnovator.org/
Learn about the LiverScope, point of care liver disease diagnostics: www.livivos.com